Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Covington
Express Scripts
Harvard Business School
AstraZeneca
Medtronic
Baxter
Healthtrust
US Army
Deloitte

Generated: January 16, 2018

DrugPatentWatch Database Preview

IOPAMIDOL-200 Drug Profile

« Back to Dashboard

When do Iopamidol-200 patents expire, and when can generic versions of Iopamidol-200 launch?

Iopamidol-200 is a drug marketed by Cook Imaging and Hospira and is included in three NDAs.

The generic ingredient in IOPAMIDOL-200 is iopamidol. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopamidol profile page.
Drug patent expirations by year for IOPAMIDOL-200
Medical Subject Heading (MeSH) Categories for IOPAMIDOL-200

US Patents and Regulatory Information for IOPAMIDOL-200

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cook Imaging IOPAMIDOL-200 iopamidol INJECTABLE;INJECTION 074881-001 Jul 28, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira IOPAMIDOL-200 iopamidol INJECTABLE;INJECTION 074898-001 Dec 30, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira IOPAMIDOL-200 IN PLASTIC CONTAINER iopamidol INJECTABLE;INJECTION 074636-001 Dec 30, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Chinese Patent Office
Medtronic
AstraZeneca
Fish and Richardson
US Army
Daiichi Sankyo
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot